These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10649732)

  • 1. Effect of intraperitoneal immunoglobulin infusion on neutrophil function in CAPD children with and without peritonitis.
    Akman S; Güven AG; Ince S; Yegin O
    Adv Perit Dial; 1998; 14():239-42. PubMed ID: 10649732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of low-dose intraperitoneal immunoglobulin administration in the treatment of peritoneal dialysis-related peritonitis.
    Coban E; Ozdogan M; Tuncer M; Bozcuk H; Ersoy F
    J Nephrol; 2004; 17(3):427-30. PubMed ID: 15365965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the epidemiological, clinical and laboratory findings in continuous ambulatory peritoneal dialysis related peritonitis attacks].
    Bulut C; Oztürk R; Yilmaz GR; Parpucu H; Irmak H; Kinikli S; Duranay M; Demiröz AP
    Mikrobiyol Bul; 2008 Apr; 42(2):255-64. PubMed ID: 18697423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-8 during peritonitis in patients treated with CAPD; an in-vivo model of acute inflammation.
    Zemel D; Krediet RT; Koomen GC; Kortekaas WM; Geertzen HG; ten Berge RJ
    Nephrol Dial Transplant; 1994; 9(2):169-74. PubMed ID: 8190331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does immunologic status predict peritonitis in children treated with CAPD?
    Aksu N; Keskinoglu A; Erdogan H; Yavascan O; Mir S; Kansoy S
    Adv Perit Dial; 1998; 14():243-6. PubMed ID: 10649733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritonitis, dialysate infusion and lung function in continuous ambulatory peritoneal dialysis (CAPD).
    Taveira da Silva AM; Davis WB; Winchester JF; Coleman DE; Weir CW
    Clin Nephrol; 1985 Aug; 24(2):79-83. PubMed ID: 3930114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of low dose immunoglobulin in the treatment of refractory CAPD peritonitis and longevity of technical survival on CAPD.
    Dursun B; Tuncer M; Felek R; Ersoy FF
    Int Urol Nephrol; 2005; 37(3):565-9. PubMed ID: 16307343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is interleukin-6 concentration in the dialysate of continuous ambulatory peritoneal dialysis patients a prognostic parameter in peritonitis?
    Fiedler R; Schneider I; Fischer K; Deuber HJ; Osten B
    Adv Perit Dial; 2001; 17():159-62. PubMed ID: 11510267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The outcome of peritonitis in patients on automated peritoneal dialysis.
    Yishak A; Bernardini J; Fried L; Piraino B
    Adv Perit Dial; 2001; 17():205-8. PubMed ID: 11510277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal interleukin-8 and neutrophil influx in the initial phase of a CAPD peritonitis.
    Betjes MG; Visser CE; Zemel D; Tuk CW; Struijk DG; Krediet RT; Arisz L; Beelen RH
    Perit Dial Int; 1996; 16(4):385-92. PubMed ID: 8863332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the phagocytic cells in children treated with continuous ambulatory peritoneal dialysis.
    Wasik M; Blaim M; Kolewska D; Janota-Krawczyk E; Tomaszewska-Pańczyk M; Sieniawska M
    Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):189-94. PubMed ID: 9597086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cefodizime on peritoneal mononuclear- and polymorphonuclear-cell chemotaxis.
    Ustün H; Ersoy FF; Sezer T; Ozcan S; Bozcuk H; Yegin O; Balci M; Süleymanlar G; Yakupoglu G
    Adv Perit Dial; 1998; 14():154-7. PubMed ID: 10649715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritonitis prevention in CAPD.
    Carozzi S; Lamperi S
    Clin Nephrol; 1988; 30 Suppl 1():S45-8. PubMed ID: 3141093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute inflammation in peritoneal dialysis: experimental studies in rats. Characterization of regulatory mechanisms.
    Bazargani F
    Swed Dent J Suppl; 2005; (171):1-57, i. PubMed ID: 15847249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic eosinophilic peritonitis in continuous ambulatory peritoneal dialysis: experience with percutaneous catheter placement.
    Jo YI; Song JO; Park JH; Lee JH; Shin SK
    Nephrology (Carlton); 2007 Oct; 12(5):437-40. PubMed ID: 17803465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritonitis in continuous ambulatory peritoneal dialysis: cytokines in peritoneal fluid and blood.
    Enríquez J; Klínger J; Arturo JA; Delgado M; Tobar C; Mosquera M
    Adv Perit Dial; 2002; 18():177-83. PubMed ID: 12402614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of CAPD patients with a high incidence of peritonitis to intraperitoneal immunoglobulin therapy.
    Carozzi S; Nasini MG; Kunkl A; Cantarella S; Lamperi S
    ASAIO Trans; 1988; 34(3):635-9. PubMed ID: 3264176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines and peritonitis in continuous ambulatory peritoneal dialysis: immunodeviation and immunodeficiency.
    Klínger J; Enríquez J; Arturo JA; Delgado M; Avila G; Ceballos O
    Adv Perit Dial; 2002; 18():170-6. PubMed ID: 12402613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of intraperitoneal urokinase for resistant bacterial peritonitis in continuous ambulatory peritoneal dialysis.
    Tong MK; Leung KT; Siu YP; Lee KF; Lee HK; Yung CY; Kwan TH; Au TC
    J Nephrol; 2005; 18(2):204-8. PubMed ID: 15931649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.